Monitoring of unbound digoxin in patients treated with anti-digoxin antigen-binding fragments: a model for the future?
Valdes
R
R
Jortani
S A
SA
D000931:Antidotes / Q000627:therapeutic use*; D001798:Blood Proteins / Q000378:metabolism; D004077:Digoxin / Q000097:blood* / Q000276:immunology / Q000506:poisoning; D006801:Humans; D007118:Immunoassay; D007140:Immunoglobulin Fab Fragments / Q000276:immunology / Q000627:therapeutic use*; D011041:Poisoning / Q000188:drug therapy; D011485:Protein Binding
D000931:Antidotes; D001798:Blood Proteins; D007140:Immunoglobulin Fab Fragments; D004077:Digoxin